APA (7th ed.) Citation

M, C., & R, B. (2022). Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm? JAMA neurology, 79(11), 1100. https://doi.org/10.1001/jamaneurol.2022.2311

Chicago Style (17th ed.) Citation

M, Chuquilin, and Barohn R. "Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?" JAMA Neurology 79, no. 11 (2022): 1100. https://doi.org/10.1001/jamaneurol.2022.2311.

MLA (9th ed.) Citation

M, Chuquilin, and Barohn R. "Rituximab in Newly Diagnosed Generalized Myasthenia Gravis: A New Treatment Paradigm?" JAMA Neurology, vol. 79, no. 11, 2022, p. 1100, https://doi.org/10.1001/jamaneurol.2022.2311.

Warning: These citations may not always be 100% accurate.